Report Detail

Other Global Circulating Tumor Cells Market Growth (Status and Outlook) 2019-2024

  • RnM2996524
  • |
  • 21 February, 2019
  • |
  • Global
  • |
  • 137 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.

According to this study, over the next five years the Circulating Tumor Cells market will register a 20.1% CAGR in terms of revenue, the global market size will reach US$ 2200 million by 2024, from US$ 730 million in 2019. In particular, this report presents the global revenue market share of key companies in Circulating Tumor Cells business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Circulating Tumor Cells market by product type, application, key companies and key regions.

This study considers the Circulating Tumor Cells value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
CTC Enrichment
CTC Detection
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Circulating Tumor Cells market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Circulating Tumor Cells market by identifying its various subsegments.
Focuses on the key global Circulating Tumor Cells players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Circulating Tumor Cells with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Circulating Tumor Cells submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Circulating Tumor Cells Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Circulating Tumor Cells Market Size 2014-2024
        • 2.1.2 Circulating Tumor Cells Market Size CAGR by Region
      • 2.2 Circulating Tumor Cells Segment by Type
        • 2.2.1 CTC Enrichment
        • 2.2.2 CTC Detection
        • 2.2.3 CTC Analysis
      • 2.3 Circulating Tumor Cells Market Size by Type
        • 2.3.1 Global Circulating Tumor Cells Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Circulating Tumor Cells Market Size Growth Rate by Type (2014-2019)
      • 2.4 Circulating Tumor Cells Segment by Application
        • 2.4.1 Breast Cancer
        • 2.4.2 Prostate Cancer
        • 2.4.3 Colorectal Cancer
        • 2.4.4 Lung Cancer
        • 2.4.5 Other
      • 2.5 Circulating Tumor Cells Market Size by Application
        • 2.5.1 Global Circulating Tumor Cells Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Circulating Tumor Cells Market Size Growth Rate by Application (2014-2019)

      3 Global Circulating Tumor Cells by Players

      • 3.1 Global Circulating Tumor Cells Market Size Market Share by Players
        • 3.1.1 Global Circulating Tumor Cells Market Size by Players (2017-2019)
        • 3.1.2 Global Circulating Tumor Cells Market Size Market Share by Players (2017-2019)
      • 3.2 Global Circulating Tumor Cells Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Circulating Tumor Cells by Regions

      • 4.1 Circulating Tumor Cells Market Size by Regions
      • 4.2 Americas Circulating Tumor Cells Market Size Growth
      • 4.3 APAC Circulating Tumor Cells Market Size Growth
      • 4.4 Europe Circulating Tumor Cells Market Size Growth
      • 4.5 Middle East & Africa Circulating Tumor Cells Market Size Growth

      5 Americas

      • 5.1 Americas Circulating Tumor Cells Market Size by Countries
      • 5.2 Americas Circulating Tumor Cells Market Size by Type
      • 5.3 Americas Circulating Tumor Cells Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Circulating Tumor Cells Market Size by Countries
      • 6.2 APAC Circulating Tumor Cells Market Size by Type
      • 6.3 APAC Circulating Tumor Cells Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Circulating Tumor Cells by Countries
      • 7.2 Europe Circulating Tumor Cells Market Size by Type
      • 7.3 Europe Circulating Tumor Cells Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Circulating Tumor Cells by Countries
      • 8.2 Middle East & Africa Circulating Tumor Cells Market Size by Type
      • 8.3 Middle East & Africa Circulating Tumor Cells Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Circulating Tumor Cells Market Forecast

      • 10.1 Global Circulating Tumor Cells Market Size Forecast (2019-2024)
      • 10.2 Global Circulating Tumor Cells Forecast by Regions
        • 10.2.1 Global Circulating Tumor Cells Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Circulating Tumor Cells Forecast by Type
      • 10.8 Global Circulating Tumor Cells Forecast by Application

      11 Key Players Analysis

      • 11.1 Menarini-Silicon Biosystems
        • 11.1.1 Company Details
        • 11.1.2 Circulating Tumor Cells Product Offered
        • 11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Menarini-Silicon Biosystems News
      • 11.2 Qiagen (Adnagen)
        • 11.2.1 Company Details
        • 11.2.2 Circulating Tumor Cells Product Offered
        • 11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Qiagen (Adnagen) News
      • 11.3 Advanced Cell Diagnostics
        • 11.3.1 Company Details
        • 11.3.2 Circulating Tumor Cells Product Offered
        • 11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Advanced Cell Diagnostics News
      • 11.4 ApoCell
        • 11.4.1 Company Details
        • 11.4.2 Circulating Tumor Cells Product Offered
        • 11.4.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 ApoCell News
      • 11.5 Epic Sciences
        • 11.5.1 Company Details
        • 11.5.2 Circulating Tumor Cells Product Offered
        • 11.5.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Epic Sciences News
      • 11.6 Greiner Bio-one GmbH
        • 11.6.1 Company Details
        • 11.6.2 Circulating Tumor Cells Product Offered
        • 11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Greiner Bio-one GmbH News
      • 11.7 Cynvenio
        • 11.7.1 Company Details
        • 11.7.2 Circulating Tumor Cells Product Offered
        • 11.7.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Cynvenio News
      • 11.8 SurExamBio-Tech
        • 11.8.1 Company Details
        • 11.8.2 Circulating Tumor Cells Product Offered
        • 11.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 SurExamBio-Tech News
      • 11.9 Fluxion Biosciences
        • 11.9.1 Company Details
        • 11.9.2 Circulating Tumor Cells Product Offered
        • 11.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Fluxion Biosciences News
      • 11.10 Ikonisys
        • 11.10.1 Company Details
        • 11.10.2 Circulating Tumor Cells Product Offered
        • 11.10.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Ikonisys News
      • 11.11 Hangzhou Watson Biotech
      • 11.12 Biocept
      • 11.13 CytoTrack
      • 11.14 Guangzhou Wondfo Biotech
      • 11.15 Celsee
      • 11.16 Clearbridge Biomedics
      • 11.17 ANGLE plc

      12 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Circulating Tumor Cells . Industry analysis & Market Report on Circulating Tumor Cells is a syndicated market report, published as Global Circulating Tumor Cells Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Circulating Tumor Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,938.98
      4,408.47
      5,877.96
      3,422.10
      5,133.15
      6,844.20
      567,775.80
      851,663.70
      1,135,551.60
      305,061.00
      457,591.50
      610,122.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report